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second MSD (MSD-2) that is interrupted by a hydrophobic segment, initially designated as HH1 (21). In addition, these proteins typically contain a hydrophobic stretch of amino acids close to the N-terminus that is preceded by several positively-charged amino acids.
ABCR shows a high degree of sequence identity to three other members of this subclass (ABC1 or ABCA1, ABC2 or ABCA2, ABC-C or ABCA3) for which the complete primary structure has been determined (1, 2, 22, 23) . For example, ABCR is over 50% identical in sequence and has a similar hydropathy profile to ABC1, a putative cholesterol transporter that has been linked to Tangier disease (21, [24] [25] [26] .
Several topological models have been proposed for ABCR and ABC1. Luciani et al. (21) , first proposed a model for ABC1 in which each half of the protein contains a NBD that is preceded by a MSD having a cluster of six transmembrane segments connected through relatively short hydrophilic segments ( Fig 1A) . A very large Nterminal cytoplasmic domain precedes MSD-1, and a large putative cytoplasmic regulatory region interrupted by a hairpin hydrophobic segment HH1 is located between NBD-1 and MSD-2. Illing et al (1) suggested a different model for ABCR (Fig 1B) . A hydrophobic segment near the N-terminus (H1) and the HH1 segment, referred to as H7, were envisioned to be transmembrane segments and each MSD was suggested to consist of five membrane spanning segments. A characteristic feature of this model is the presence of two very large exocytoplasmic (extracellular/lumenal) domains in both the N and C terminal halves of the protein and the absence of the large cytoplasmic regulatory domain. Finally, Azarian and Travis (3) and more recently Sun et al. (27) proposed a hybrid model for ABCR that has some features of the first two models (Fig 1C) . More specifically, in their model, the topology of the C-terminal half is similar to the model in Fig 1A with a HH1 segment that only partially inserts into the membrane, and the Nterminal half shows structural features of the model in Fig 1B with a H1 transmembrane segment at the N-terminus. A similar hybrid model has been recently proposed for ABC1 (28) . N-linked glycosylation is known to occur on an asparagine residue (N) within a consensus sequence (-N-X-S/T-). Since N-linked glycosylation is known to take place on the lumen side of the endoplasmic reticulum, it can be used to define exocytoplasmic domains of membrane proteins. In this paper, we have identified the N-linked glycosylation sites on ABCR using trypsin digestion of ABCR in native ROS membranes, site-directed mutagenesis of heterologously expressed ABCR, concanavalin A labeling and endoglycosidase digestion. We show that ABCR has four N-linked glycosylation sites on each half of the protein. These sites are positioned within a 600 amino acid segment between H1 and MSD-1 in the N half and a 275 amino acid segment between H7 and MSD-2 in the C half of ABCR, thereby supporting the existence of two large ECDs as depicted in the model shown in Fig1B. Other members of the ABCA subclass of transporters including ABC1 and ABC2 display considerable sequence similarity to ABCR within the ECDs, and therefore are likely to exhibit a similar membrane topology and domain organization as ABCR. We also provide evidence that the C and N halves of ABCR interact through disulfide bonds. These studies provide new insight into the organization of ABCR and other ABCA transporters in the membrane and define domains that are present on the exocytoplasmic side of the membrane. Tris buffer for 20 min to block any reactive sulfhydryl groups prior to analysis by SDS gel electrophoresis and Western blotting as previously described (30) .
Monoclonal Antibodies-The Rim 3F4 monoclonal antibody against an epitope (YDLPLHPRT) near the C-terminus of bovine ABCR has been described (1). The Rim 5B4 monoclonal antibody (6) was generated from a mouse immunized with a fusion protein consisting of amino acids 113-883 of human ABCR in frame with glutathione-S-transferase. The binding site for the Rim 5B4 antibody (LEDTGLHHK) was determined by epitope mapping using synthetic peptides as previously described (1) .
Generation of ABCR Mutants-The human ABCR cDNA (2), a generous gift of Jeremy Nathans, was subcloned into pcDNA3 (Invitrogen, Carlsbad, CA) as previously reported (9) and is designated as pcDNA3/ABCR. The serine (S) or threonine (T) residue within the consensus sequence (-N-X-S/T-) for N-linked glycosylation was replaced with an alanine (A) to prevent glycosylation on the asparagine residue (N). ABCR (∆8) had mutations in eight N-linked glycosylation sites within two ECDs at the following positions: N98 (S100A), N415 (T417A), N444 (T446A), N504 (T506A), N1469 (T1471A), N1529 (S1531A), N1588 (S1590A) and N1662 (T1664A) as shown in Fig 2. All mutations were produced with the QuikChange Site-Directed Mutagenesis Kit (Stratagene, San Diego, CA) using the appropriate synthetic oligonucleotides. A truncated ABCR (N-tr-ABCR) was generated by digesting pcDNA3/ABCR with NarI to remove the C-terminal half of ABCR. Mutations at glycosylation sites N98 (S100A), N415 (T417A), N444 (T446), N504 (T506A) were constructed as described above and are listed in Table I . The DNA sequences of all constructs were determined to verify the presence of the desired mutation and the absence of random mutations.
COS-1 Cell Transfection and Membrane
Preparation-COS-1 cells were maintained as described (9) . Typically, cells in one 10-cm dish were transfected with 30 µg of the pcDNA plasmid containing WT or mutant ABCR using the calcium phosphate procedure 
RESULTS

Both the N-and C-terminal Halves of ABCR in ROS Are Glycosylated-Previous
concanavalin A binding and endoglycosidase digestion studies have shown that ABCR is a membrane glycoprotein with one or more oligosaccharide chains (1, 32) . To determine if the glycosylation sites are located on the N-terminal half, the C-terminal half, or both halves of the protein, ABCR in ROS membranes was cleaved in half with trypsin (1) and the complex was immunoprecipitated with the Rim 3F4 monoclonal antibody coupled to Sepharose. The fragments were separated on SDS gels and analyzed on Western blots probed with monoclonal antibodies to an epitope within the N-terminal half (Rim 5B4) and the C-terminal half (Rim 3F4) and with concanavalin A. 
N-linked Glycosylation Sites Are Present within the Two Large Exocytoplasmic
Domains (ECDs) of ABCR-Primary structural analysis indicates that there are 17 consensus sequences (-N-X-S/T-) for N-linked glycosylation in human ABCR.
However, most of these are present in the NBDs and in or near the putative transmembrane segments and therefore are not predicted to be glycosylated. We reasoned that the glycosylation sites most likely reside within the large hydrophilic domains of ABCR. Using the model of Illing et al. (1), we selected the 8 consensus sequences for N-linked glycosylation located in ECD-1 and ECD-2 for detailed studies (Fig 2) . A series of ABCR mutants were constructed in which the serine (S) or threonine (T) residues in the consensus sequences were replaced with an alanine (A), thereby preventing glycosylation (Table I ).
In initial studies three constructs were made: one containing mutations in the four consensus glycosylation sequences within ECD-1 (ABCR (∆4N)); one containing mutations in the four consensus sequences within ECD-2 (ABCR (∆4C)); and one with mutations at all eight sites (ABCR (∆8)). The WT and mutant ABCR proteins were expressed in COS-1 cells, immunoprecipitated and analyzed on Western blots labeled with the Rim 3F4 antibody and concanavalin A. The expression levels varied for the different proteins. Typically, the ABCR (∆4) mutants expressed at roughly 75% that of WT, whereas the ABCR (∆8) expression was considerably lower, and generally less than 20% that of WT. Similar amounts of the expressed ABCR protein were applied to the lanes of a SDS polyacrylamide gel for comparative analysis. suggesting that H1 of ABCR is a membrane spanning segment is consistent with recent studies (28) showing that the analogous segment in ABC1 serves as a signal-anchor sequence important in the translocation of the ECD-1 into the exocytoplasmic space.
Previously, it has been reported that mutant forms of P-glycoprotein can adopt multiple membrane topographies which differ in glycosylation and mobility on SDS gels suggesting that these sites are important. Our studies indicate that expression levels are reduced when all or most of the glycosylation sites are removed, although these mutants still retain the capacity to bind ATP. These results suggest that glycosylation may play a role in stabilizing ABCR against degradation during biosynthetic processing in the endoplasmic reticulum. A similar effect has been reported for P-glycoprotein (37) . In this study deglycosylated P-glycoprotein was shown to be active as a transporter.
However, the number of cells that confer drug resistance was significantly lower than for WT P-glycoprotein. This has been interpreted to indicate that the oligosaccharide chains are important in stabilizing the protein and/or for the sorting of P-glycoprotein to the plasma membrane.
To date over 180 mutations in ABCR have been linked to Stargardt macular degeneration and related retinal dystrophies (2,10-13,19) (38) . Missense mutations are distributed evenly throughout the ABCA4 gene. A scan of disease causing mutations reveals that one mutation (S100P) in a N-linked glycosylation site has been found in a patient with Stargardt's disease (38) . This mutation would prevent the occurrence of Nlinked glycosylation on N98, but it may also affect the folding of the protein due to the introduction of a proline residue. Analysis of the expression level and ATPase activity of the S100P mutant may provide insight into the effect of this mutation on the structurefunction relationships of ABCR as has been carried out for other disease-linked mutations (27) . cysteine residues that are located in ECDs exposed to the oxidizing environment of the disk lumen. ECD-1 and ECD-2 of human ABCR contain 9 and 5 cysteine residues, respectively, all of which are conserved in bovine and mouse ABCR. On this basis, we suggest that the ECD-1 and ECD-2 regions are in close proximity to one another and stabilized by one or more disulfide bonds (Fig 8) . The importance of cysteine residues in the ECDs is underscored by their involvement in disease states. Several missense mutations in cysteine residues within ECD-1 (C54Y, C75G) and ECD-2 (C1488R,C1490Y) have been linked to Stargardt disease (13, 19, 38, 39) . In addition missense mutations leading to the introduction of a cysteine residue within the ECDs have also been found in individuals with Stargardt disease (13, 40) . Removal or introduction of cysteine residues into exocytoplasmic domains can alter disulfide Only one large ECD (ECD-1) is present and the HH1 segment that partially inserts into the bilayer is retained. Bovine ROS membranes were digested with trypsin and subjected to SDS gel electrophoresis under disulfide reducing (+β-mercaptoethanol) and nonreducing (-β-mercaptoethanol) conditions. Western blots were labeled with the Rim 3F4 and Rim 5B4 antibodies. none S100A, T417A, T446A, T506A T1471A, S1531A, S1590A, T1664A ABCR (∆4Ν) N1469, N1529, N1588, N1662 S100A, T417A, T446A, T506A
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ABCR (∆4C) N98, N415, N444, N504 T1471A, S1531A, S1590A, T1664A
ABCR (∆7-N1469) N1469 S100A, T417A, T446A, T506A T1471A, S1531A, S1590A
ABCR (∆7-N1529) N1529 S100A, T417A, T446A, T506A T1471A, S1531A, T1664A
ABCR (∆7-N1588) N1588 S100A, T417A, T446A, T506A T1471A, S1590A, T1664A ABCR (∆7-N1662) N1662 S100A, T417A, T446A, T506A S1531A, S1590A, T1664A N-tr-ABCR N98, N415, N444, N504 none N-tr-ABCR (∆4) none S100A, T417A, T446A, T506A N-tr-ABCR (∆3-N98)  N98  T417A, T446A, T506A  N-tr-ABCR (∆3-N415) N415 S100A, T446A, T506A N-tr-ABCR (∆3-N444) N444 S100A, T417A, T506A
N-tr-ABCR (∆3-N504)   N504  S100A, T417A, T446A   35 by guest on November 6, 2017
